Vaccinex Inc. (NASDAQ: VCNX) stock fell -6.27% on Friday to $0.18 against a previous-day closing price of $0.20. With 0.93 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.15 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1974 whereas the lowest price it dropped to was $0.1737. The 52-week range on VCNX shows that it touched its highest point at $0.83 and its lowest point at $0.19 during that stretch. Beta for the stock currently stands at 0.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VCNX was down-trending over the past week, with a drop of -12.43%, but this was down by -12.84% over a month. Three-month performance dropped to -58.20% while six-month performance fell -55.52%. The stock lost -76.12% in the past year, while it has lost -71.47% so far this year.
Float and Shares Shorts:
At present, 69.08 million VCNX shares are outstanding with a float of 61.21 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.13 million, which was 0.19% higher than short shares on Jul 30, 2023. In addition to Dr. Maurice Zauderer Ph.D. as the firm’s Co-Founder, CEO, Pres & Director, Dr. Elizabeth E. Evans Ph.D. serves as its COO and Sr. VP of Discovery & Translational Medicine.
Through their ownership of 50.21% of VCNX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 68.03% of VCNX, in contrast to 3.30% held by mutual funds. Shares owned by individuals account for 1.40%. As the largest shareholder in VCNX with 1.96% of the stake, AIGH Capital Management LLC holds 1,352,570 shares worth 1,352,570. A second-largest stockholder of VCNX, The Vanguard Group, Inc., holds 723,304 shares, controlling over 1.05% of the firm’s shares. Telemetry Investments LLC is the third largest shareholder in VCNX, holding 416,000 shares or 0.60% stake. With a 0.77% stake in VCNX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 534,485 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.27% of VCNX stock, is the second-largest Mutual Fund holder. It holds 188,819 shares valued at 38330.0. Fidelity Extended Market Index Fu holds 0.24% of the stake in VCNX, owning 164,149 shares worth 33322.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, VCNX reported revenue of $0.00 and operating income of -$5.40M. The EBITDA in the recently reported quarter was -$5.33M and diluted EPS was -$0.13.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VCNX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With VCNX analysts setting a high price target of $7.00 and a low target of $7.00, the average target price over the next 12 months is $7.00. Based on these targets, VCNX could surge 3788.89% to reach the target high and rise by 3788.89% to reach the target low. Reaching the average price target will result in a growth of 3788.89% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded VCNX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 8 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 17,119,753 while 0 shares were sold.